Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol Acetate in Persistent Asthma
NCT01609478Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of indacaterol in asthma, sponsored by Novartis. Started Aug 2012; status: completed.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01609478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01609478.